In a significant development for the Turkish chemical industry, Toros Ecza ve Kimyevi Maddeler has formally declared that it has joined the Albar Group of Companies. This strategic acquisition, which marks a new chapter for the brand, aims to integrate Toros Ecza’s deep-rooted sectoral experience with the robust corporate infrastructure of the Albar Group.
A 74-Year Legacy Meets Corporate Strength
Founded in 1952, Toros Ecza has built its reputation on the pillars of quality, trust, and ethical commerce. For over seven decades, the company has served as a critical supplier for Turkey's industrial, academic, and clinical research laboratories. In an official statement, the company expressed its pride in transitioning this long-standing heritage into a stronger structure that shares the same fundamental corporate values, ensuring its continuity and future growth.
Continued Commitment to Global Partnerships
One of the key strengths of Toros Ecza has been its ability to foster long-term, trust-based relationships with globally renowned industry leaders. The company confirmed that these critical alliances—most notably with Merck Life Science—will continue to flourish under the new ownership. By aligning with the Albar Group's vision and corporate strategy, Toros Ecza intends to further enhance these partnerships, ensuring high-quality service and supply chain continuity for its stakeholders.
Creating New Opportunities for All Stakeholders
Looking ahead, Toros Ecza management emphasized that this new era is designed to create fresh opportunities for employees, customers, suppliers, and business partners. Thanking all those who contributed to this significant transition, the management stated, "Knowing that the 74-year legacy of Toros Ecza will be carried forward by such capable hands gives us great happiness. We wish this partnership to be beneficial for all our stakeholders."
